Kairos Pharma Ltd. (KAPA)
AMEX: KAPA
· Real-Time Price · USD
1.19
-0.05 (-4.03%)
At close: Aug 15, 2025, 3:59 PM
1.22
2.62%
Pre-market: Aug 18, 2025, 09:25 AM EDT
Kairos Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Net Income | -4.71M | -3.54M | -2.6M | -2.74M | -2.01M | -1.99M | -1.81M | -890K | -812K | -961K | -1.05M | -854K | -620K | -235K |
Depreciation & Amortization | 160K | 160K | 160K | 160K | 160K | 170K | 180K | 190K | 280K | 520K | 568K | 518K | 388K | 98K |
Stock-Based Compensation | 294K | 294K | 218K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -375K | 320K | n/a | -1.17M | 883K | 848K | 532K | 332K | -16K | -3K | n/a | -5K | -10K | -14K |
Other Non-Cash Items | -394K | -1.75M | -1.73M | 1.66M | 988K | 1.1M | 1.18M | 314K | 351K | 231K | 129K | 57K | 10K | 3K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -691K | 133K | n/a | -1.17M | 883K | 848K | 532K | 332K | -16K | -3K | n/a | -5K | -10K | -14K |
Operating Cash Flow | -5.34M | -4.71M | -3.96M | -2.09M | 25K | 125K | 81K | -54K | -197K | -213K | -353K | -284K | -232K | -148K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | 102K | 102K | 142K | 102K | n/a | n/a | n/a | 225K | 675K | 925K | 925K | 700K | 250K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 121K | -102K | -102K | -390K | n/a | -57K | -129K | -146K | -180K | -270K | -208K | -191K | -157K | -10K |
Financial Cash Flow | 8.36M | 8.28M | 5.13M | 5.2M | -236K | -442K | -425K | -370K | 45K | 405K | 717K | 734K | 543K | 240K |
Net Cash Flow | 3.01M | 3.58M | 1.18M | 3.12M | -211K | -317K | -344K | -424K | -152K | 192K | 437K | 523K | 384K | 165K |
Free Cash Flow | -5.34M | -4.71M | -3.96M | -2.09M | 25K | 125K | 81K | -54K | -197K | -213K | -353K | -284K | -232K | -148K |